Neil W Gibson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Neil W Gibson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neil W Gibson. Neil W Gibson is Chief Scientific Officer in Regulus Therapeutics Inc. ($RGLS) and Director in Shattuck Labs, Inc. ($STTK) and Director in TCR2 THERAPEUTICS INC. ($TCRR) and Director in Instil Bio, Inc. ($TIL).
Latest Insider Trading Transactions of Neil W Gibson
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TIL, RGLS, STTK, TCRR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | TIL | Instil Bio, Inc. | Gibson Neil W | Director | Option Exercise | A | 20.00 | 52,000 | 1,040,000 | 52,000 | |
| Dec 28 2020 | STTK | Shattuck Labs, Inc ... | Gibson Neil W | Director | Option Exercise | A | 53.02 | 1,286 | 68,184 | 1,286 | |
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | A | 31.83 | 12,100 | 385,143 | 12,100 | |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 7.94 | 648 | 5,145 | 0 | 648 to 0 (-100.00 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 7.41 | 3,140 | 23,267 | 648 | 3.8 K to 648 (-82.89 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.83 | 3,120 | 21,310 | 3,788 | 6.9 K to 3.8 K (-45.17 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.49 | 3,009 | 19,528 | 6,908 | 9.9 K to 6.9 K (-30.34 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.60 | 17,723 | 117,043 | 9,917 | 27.6 K to 9.9 K (-64.12 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.52 | 52,000 | 338,894 | 27,640 | 79.6 K to 27.6 K (-65.29 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 217,974 | 0 | 79,640 | 297.6 K to 79.6 K (-73.24 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 196,177 | 0 | 297,614 | 493.8 K to 297.6 K (-39.73 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 212,560 | 0 | 493,791 | 706.4 K to 493.8 K (-30.09 %) |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | A | 16.10 | 5,000 | 80,500 | 5,000 | |
| Apr 12 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | A | 16.11 | 6,270 | 101,010 | 6,270 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | C | 0.00 | 4,375,000 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Buy | C | 0.00 | 706,351 | 0 | 706,351 | 0 to 706.4 K |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | C | 0.00 | 4,375,000 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Buy | C | 0.00 | 706,351 | 0 | 706,351 | 0 to 706.4 K |
| Jun 18 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 5,000 | 8,700 | 126,500 | |
| Jun 18 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.05 | 5,000 | 40,227 | 80,000 | 85 K to 80 K (-5.88 %) |
| Jun 18 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 5,000 | 8,700 | 85,000 | 80 K to 85 K (+6.25 %) |
| Apr 10 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,500 | 4,350 | 42,591 | |
| Apr 10 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.11 | 2,500 | 20,271 | 80,000 | 82.5 K to 80 K (-3.03 %) |
| Apr 10 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,500 | 4,350 | 82,500 | 80 K to 82.5 K (+3.13 %) |
| Mar 07 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,500 | 4,350 | 45,091 | |
| Mar 07 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 11.37 | 2,500 | 28,429 | 80,000 | 82.5 K to 80 K (-3.03 %) |
| Mar 07 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,500 | 4,350 | 82,500 | 80 K to 82.5 K (+3.13 %) |
| Feb 07 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 45,000 | 78,300 | 2,591 | |
| Feb 07 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,500 | 4,350 | 47,591 | |
| Feb 07 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 45,000 | 78,300 | 80,000 | 35 K to 80 K (+128.57 %) |
| Feb 07 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.38 | 17,500 | 146,706 | 35,000 | 52.5 K to 35 K (-33.33 %) |
| Feb 07 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,500 | 4,350 | 52,500 | 50 K to 52.5 K (+5.00 %) |
| Jan 23 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 2.66 | 4,421 | 11,760 | 701 | |
| Jan 23 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.09 | 4,421 | 35,764 | 50,000 | 54.4 K to 50 K (-8.12 %) |
| Jan 23 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 2.66 | 4,421 | 11,760 | 54,421 | 50 K to 54.4 K (+8.84 %) |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 2.66 | 2,079 | 5,530 | 5,122 | |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,400 | 4,176 | 50,091 | |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.15 | 4,479 | 36,494 | 50,000 | 54.5 K to 50 K (-8.22 %) |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 2.66 | 2,079 | 5,530 | 54,479 | 52.4 K to 54.5 K (+3.97 %) |
| Jan 21 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,400 | 4,176 | 52,400 | 50 K to 52.4 K (+4.80 %) |
| Jan 17 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 1,100 | 1,914 | 52,491 | |
| Jan 17 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.03 | 1,100 | 8,837 | 50,000 | 51.1 K to 50 K (-2.15 %) |
| Jan 17 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 1,100 | 1,914 | 51,100 | 50 K to 51.1 K (+2.20 %) |
| Dec 16 2013 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | A | 6.13 | 100,000 | 613,000 | 100,000 | |
| Feb 14 2013 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 50,000 | 87,000 | 133,909 | |
| Feb 14 2013 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 50,000 | 87,000 | 50,000 | 0 to 50 K |
| Dec 13 2012 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | A | 4.44 | 112,500 | 499,500 | 112,500 |
Page: 1